Quantum plavix?

See the DrugPatentWatch profile for plavix

What is the connection between Quantum and Plavix?

Quantum is a pharmaceutical company, and Plavix is a popular antiplatelet medication used to reduce the risk of heart disease and stroke. There is no direct product or licensing agreement between Quantum and Plavix.

However, Quantum Pharmaceuticals does market a generic version of clopidogrel, the active ingredient in Plavix, under the brand name Plavix in some markets.[1] Quantum Pharmaceuticals acquired the rights to manufacture and distribute Plavix after the patents for the original formulation expired.

Comparison with brand-name Plavix

Quantum's generic clopidogrel is bioequivalent to the brand-name Plavix, meaning that it has the same active ingredient and potency. However, the generic version is typically cheaper and can be a more cost-effective option for patients. [2]

Impact of patent expiry

The original patent for Plavix expired in 2011, allowing generic manufacturers like Quantum Pharmaceuticals to develop and market their own versions of the medication. This has led to increased competition and lower prices for patients taking clopidogrel.

Sources:

[1] DrugPatentWatch.com
[2] Quantum Pharmaceuticals, Product Information

Additional Reading:

* What happens to generic drug prices after patent expiry?
* How does the FDA regulate generic medications?
* Can patients switch between brand-name and generic Plavix?